Leukemia & Lymphoma, Volume 55, Issue 9 (2014)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 55, Issue 9 (2014)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Volume 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries on selected articles in this issue

Article Commentary
Issues of front-line therapy for multiple myeloma – the standard of care
Laura Rosiñol & Joan Bladé
Pages: 1959-1961
Published online: 20 Mar 2014
First Page PreviewforIssues of front-line therapy for multiple myeloma – the standard of care | Full Text | References | PDF (93.7 KB) | Supplemental
  • 879 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Commentary

Article Commentary
Potential new risks of lenalidomide
Morie A. Gertz & Francis K. Buadi
Pages: 1962-1963
Published online: 28 Jan 2014
CitationforPotential new risks of lenalidomide | Full Text | References | PDF (81.1 KB) | Supplemental
  • 891 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Lymphoma associated hemophagocytic syndrome: it's going viral
James Hoffman & Izidore S. Lossos
Pages: 1964-1965
Published online: 16 Jun 2014
CitationforLymphoma associated hemophagocytic syndrome: it's going viral | Full Text | References | PDF (85.3 KB) | Supplemental
  • 1227 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Targeting drug resistance to close the gap in diffuse large B-cell lymphoma
Deborah Rund
Pages: 1966-1967
Published online: 25 Mar 2014
CitationforTargeting drug resistance to close the gap in diffuse large B-cell lymphoma | Full Text | References | PDF (87.6 KB) | Supplemental
  • 729 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Reviews

Review Article
Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies
Tariq I. Mughal, Saulius Girnius, Steven T. Rosen, Shaji Kumar, Adrian Wiestner, Omar Abdel-Wahab, Jean-Jacques Kiladjian, Wyndham H. Wilson & Richard A. Van Etten
Pages: 1968-1979
Published online: 17 Feb 2014
AbstractforEmerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies | Full Text | References | PDF (1.8 MB) | Supplemental
  • 378 Views
  • 18 CrossRef citations
  • 0Altmetric

Review Article

Review Article
Targeting the apoptosis pathway in hematologic malignancies
Shadia Zaman, Rui Wang & Varsha Gandhi
Pages: 1980-1992
Published online: 04 Feb 2014
AbstractforTargeting the apoptosis pathway in hematologic malignancies | Full Text | References | PDF (572.5 KB) | Supplemental
  • 699 Views
  • 141 CrossRef citations
  • 0Altmetric
Review Article
Rho and Rap guanosine triphosphatase signaling in B cells and chronic lymphocytic leukemia
Silvia Mele, Stephen Devereux & Anne J. Ridley
Pages: 1993-2001
Published online: 31 Dec 2013
AbstractforRho and Rap guanosine triphosphatase signaling in B cells and chronic lymphocytic leukemia | Full Text | References | PDF (606.6 KB) | Supplemental
  • 429 Views
  • 5 CrossRef citations
  • 0Altmetric
Review Article
Acute myeloid leukemia with DNMT3A mutations
Yunlong Li & Baosheng Zhu
Pages: 2002-2012
Published online: 07 Mar 2014
AbstractforAcute myeloid leukemia with DNMT3A mutations | Full Text | References | PDF (577.3 KB) | Supplemental
  • 1097 Views
  • 13 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Article
A multicenter phase II study of single-agent enzastaurin in previously treated multiple myeloma
Eric Jourdan, Veronique Leblond, Hervé Maisonneuve, Karim A. Benhadji, Anwar M. Hossain, Tuan S. Nguyen, James E. Wooldridge & Philippe Moreau
Pages: 2013-2017
Published online: 02 May 2014
AbstractforA multicenter phase II study of single-agent enzastaurin in previously treated multiple myeloma | Full Text | References | PDF (122.1 KB) | Supplemental
  • 222 Views
  • 14 CrossRef citations
  • 0Altmetric

Research Article

Article
Lenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis
Flora Zagouri, Efstathios Kastritis, Maria Gavriatopoulou, Theodoros N. Sergentanis, Theodora Psaltopoulou, Evangelos Terpos & Meletios-Athanasios Dimopoulos
Pages: 2018-2023
Published online: 17 Feb 2014
AbstractforLenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis | Full Text | References | PDF (361.1 KB) | Supplemental
  • 1104 Views
  • 51 CrossRef citations
  • 0Altmetric
Article
Bortezomib and lenalidomide as front-line therapy for multiple myeloma
Yandun Zou, Mingzhen Lin, Zhixin Sheng & Shaona Niu
Pages: 2024-2031
Published online: 06 Nov 2013
AbstractforBortezomib and lenalidomide as front-line therapy for multiple myeloma | Full Text | References | PDF (1.8 MB) | Supplemental
  • 943 Views
  • 14 CrossRef citations
  • 0Altmetric
Article
Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide
Vittorio Montefusco, Monica Galli, Francesco Spina, Paola Stefanoni, Alberto Mussetti, Giulia Perrone, Chiara De Philippis, Serena Dalto, Francesco Maura, Chiara Bonini, Francesca Rezzonico, Martina Pennisi, Luisa Roncari, Martina Soldarini, Anna Dodero, Lucia Farina, Federica Cocito, Chiara Caprioli & Paolo Corradini
Pages: 2032-2037
Published online: 05 Jun 2014
AbstractforAutoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide | Full Text | References | PDF (159.3 KB) | Supplemental
  • 1028 Views
  • 22 CrossRef citations
  • 0Altmetric
Article
Epstein–Barr virus present in T cells or B cells shows differential effects on hemophagocytic symptoms associated with outcome in T-cell lymphomas
Ya-Ping Chen, Dan Jones, Tsai-Yun Chen & Kung-Chao Chang
Pages: 2038-2047
Published online: 17 Feb 2014
AbstractforEpstein–Barr virus present in T cells or B cells shows differential effects on hemophagocytic symptoms associated with outcome in T-cell lymphomas | Full Text | References | PDF (19.4 MB) | Supplemental
  • 384 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Clinical features and treatment of natural killer/T cell lymphoma associated with hemophagocytic syndrome: comparison with other T cell lymphoma associated with hemophagocytic syndrome
Lijuan Han, Ling Li, Jingjing Wu, Xin Li, Lei Zhang, Xinhua Wang, Xiaorui Fu, Wang Ma, Zhenchang Sun, Xudong Zhang, Yu Chang, Shuxia Guo & Mingzhi Zhang
Pages: 2048-2055
Published online: 24 Feb 2014
AbstractforClinical features and treatment of natural killer/T cell lymphoma associated with hemophagocytic syndrome: comparison with other T cell lymphoma associated with hemophagocytic syndrome | Full Text | References | PDF (247.3 KB) | Supplemental
  • 454 Views
  • 25 CrossRef citations
  • 0Altmetric
Article
Polycomb protein EZH2 expression in diffuse large B-cell lymphoma is associated with better prognosis in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone
Hyun Jung Lee, Dong Hoon Shin, Kyung Bin Kim, Nari Shin, Won Young Park, Jung Hee Lee, Kyung Un Choi, Jee Yeon Kim, Chang Hun Lee & Mee Young Sol
Pages: 2056-2063
Published online: 24 Feb 2014
AbstractforPolycomb protein EZH2 expression in diffuse large B-cell lymphoma is associated with better prognosis in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone | Full Text | References | PDF (1.6 MB) | Supplemental
  • 418 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Results of a prospective phase II trial evaluating interim positron emission tomography-guided high dose therapy for poor prognosis diffuse large B-cell lymphoma
Douglas A. Stewart, Reinhard Kloiber, Carolyn Owen, Nizar J. Bahlis, Peter Duggan, Adnan Mansoor & Isabelle Bence-Bruckler
Pages: 2064-2070
Published online: 17 Feb 2014
AbstractforResults of a prospective phase II trial evaluating interim positron emission tomography-guided high dose therapy for poor prognosis diffuse large B-cell lymphoma | Full Text | References | PDF (357.1 KB) | Supplemental
  • 359 Views
  • 20 CrossRef citations
  • 0Altmetric
Article
Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma
Stefania Nobili, Cristina Napoli, Benedetta Puccini, Ida Landini, Gabriele Perrone, Marco Brugia, Gemma Benelli, Morena Doria, Maurizio Martelli, Erica Finolezzi, Alice Di Rocco, Emanuele Del Fava, Luigi Rigacci, Simonetta Di Lollo, Alberto Bosi & Enrico Mini
Pages: 2071-2078
Published online: 24 Feb 2014
AbstractforIdentification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma | Full Text | References | PDF (425.9 KB) | Supplemental
  • 259 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
Michael J. Conte, Deborah A. Bowen, Gregory A. Wiseman, Kari G. Rabe, Susan L. Slager, Susan M. Schwager, Timothy G. Call, David S. Viswanatha & Clive S. Zent
Pages: 2079-2084
Published online: 17 Feb 2014
AbstractforUse of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma | Full Text | References | PDF (691.7 KB) | Supplemental
  • 300 Views
  • 34 CrossRef citations
  • 0Altmetric
Article
Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia
Pauline Y. Huang, Oliver G. Best, Juhura G. Almazi, Larissa Belov, Zadie A. Davis, Aneela Majid, Martin J. Dyer, Dana Pascovici, Stephen P. Mulligan & Richard I. Christopherson
Pages: 2085-2092
Published online: 24 Jan 2014
AbstractforCell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia | Full Text | References | PDF (2.5 MB) | Supplemental
  • 1161 Views
  • 24 CrossRef citations
  • 0Altmetric
Article
Efficacy and safety of dasatinib versus imatinib in the East Asian subpopulation of the DASISION trial of newly diagnosed chronic myeloid leukemia in chronic phase
Charles T. Chuah, Hirohisa Nakamae, Zhixiang X. Shen, M. Brigid Bradley-Garelik & Dong-Wook Kim
Pages: 2093-2100
Published online: 12 Mar 2014
AbstractforEfficacy and safety of dasatinib versus imatinib in the East Asian subpopulation of the DASISION trial of newly diagnosed chronic myeloid leukemia in chronic phase | Full Text | References | PDF (1.1 MB) | Supplemental
  • 2141 Views
  • 25 CrossRef citations
  • 0Altmetric
Open Access
Article
CAMKIIγ, HSP70 and HSP90 transcripts are differentially expressed in chronic myeloid leukemia cells from patients with resistant mutated disease
Mariana Gonzalez, Carlos De Brasi, Cristian Ferri, Raquel Bengió, Michele Bianchini & Irene Larripa
Pages: 2101-2108
Published online: 07 Mar 2014
AbstractforCAMKIIγ, HSP70 and HSP90 transcripts are differentially expressed in chronic myeloid leukemia cells from patients with resistant mutated disease | Full Text | References | PDF (2.4 MB) | Supplemental
  • 169 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Pregnancy outcomes in patients with chronic myeloid leukemia treated with imatinib mesylate: short report from a developing country
Javaid Iqbal, Zafar Ali, Aruj-un-Nisa Khan & Zeba Aziz
Pages: 2109-2113
Published online: 17 Feb 2014
AbstractforPregnancy outcomes in patients with chronic myeloid leukemia treated with imatinib mesylate: short report from a developing country | Full Text | References | PDF (120 KB) | Supplemental
  • 544 Views
  • 25 CrossRef citations
  • 0Altmetric
Article
A phase II study of elacytarabine in combination with idarubicin and of human equilibrative nucleoside transporter 1 expression in patients with acute myeloid leukemia and persistent blasts after the first induction course
David Rizzieri, Norbert Vey, Xavier Thomas, Françoise Huguet-Rigal, Richard F. Schlenk, Jürgen Krauter, Thomas Kindler, Bjørn Tore Gjertsen, Igor Wolfgang Blau, Tove Flem Jacobsen, Malin Johansen, Trygve Bergeland, Athos Gianella-Borradori & Utz Krug
Pages: 2114-2119
Published online: 24 Jan 2014
AbstractforA phase II study of elacytarabine in combination with idarubicin and of human equilibrative nucleoside transporter 1 expression in patients with acute myeloid leukemia and persistent blasts after the first induction course | Full Text | References | PDF (197.8 KB) | Supplemental
  • 214 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Increased expression of costimulatory molecules CD86 and sCTLA-4 in patients with acute lymphoblastic leukemia
Amany Mansour, Tawfik Elkhodary, Ahmad Darwish & Mohamed Mabed
Pages: 2120-2124
Published online: 07 Mar 2014
AbstractforIncreased expression of costimulatory molecules CD86 and sCTLA-4 in patients with acute lymphoblastic leukemia | Full Text | References | PDF (125.9 KB) | Supplemental
  • 339 Views
  • 19 CrossRef citations
  • 0Altmetric
Article
Acute myeloid leukemia presenting with panhypopituitarism or diabetes insipidus: a case series with molecular genetic analysis and review of the literature
Elizabeth H. Cull, Justin M. Watts, Martin S. Tallman, Peter Kopp, Mark Frattini, Franck Rapaport, Raajit Rampal, Ross Levine & Jessica K. Altman
Pages: 2125-2129
Published online: 24 Feb 2014
AbstractforAcute myeloid leukemia presenting with panhypopituitarism or diabetes insipidus: a case series with molecular genetic analysis and review of the literature | Full Text | References | PDF (304.9 KB) | Supplemental
  • 626 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
Association of XRCC3 Thr241Met polymorphism and leukemia risk: evidence from a meta-analysis
Yulan Yan, Hongjie Liang, Taijie Li, Shihui Guo, Meng Li, Xue Qin & Shan Li
Pages: 2130-2134
Published online: 04 Feb 2014
AbstractforAssociation of XRCC3 Thr241Met polymorphism and leukemia risk: evidence from a meta-analysis | Full Text | References | PDF (191.5 KB) | Supplemental
  • 110 Views
  • 8 CrossRef citations
  • 0Altmetric

Original Articles: Research

Article
Cariporide sensitizes leukemic cells to tumor necrosis factor related apoptosis-inducing ligand by up-regulation of death receptor 5 via endoplasmic reticulum stress–CCAAT/enhancer binding protein homologous protein dependent mechanism
Huawen Li, Guoqiang Chang, Jian Wang, Lihong Wang, Weina Jin, Yani Lin, Yan Yan, Ruojun Wang, Wei Gao, Li Ma, Qinghua Li & Tianxiang Pang
Pages: 2135-2140
Published online: 04 Aug 2014
AbstractforCariporide sensitizes leukemic cells to tumor necrosis factor related apoptosis-inducing ligand by up-regulation of death receptor 5 via endoplasmic reticulum stress–CCAAT/enhancer binding protein homologous protein dependent mechanism | Full Text | References | PDF (784.6 KB) | Supplemental
  • 201 Views
  • 11 CrossRef citations
  • 0Altmetric

Research Article

Article
The anti-lymphoma activity of APO866, an inhibitor of nicotinamide adenine dinucleotide biosynthesis, is potentialized when used in combination with anti-CD20 antibody
Aimable Nahimana, Dominique Aubry, Caroline S. Breton, Somi R. Majjigapu, Bernard Sordat, Pierre Vogel & Michel A. Duchosal
Pages: 2141-2150
Published online: 24 Jan 2014
AbstractforThe anti-lymphoma activity of APO866, an inhibitor of nicotinamide adenine dinucleotide biosynthesis, is potentialized when used in combination with anti-CD20 antibody | Full Text | References | PDF (1.4 MB) | Supplemental
  • 314 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Enhanced anti-tumor activity of the glycoengineered type II CD20 antibody obinutuzumab (GA101) in combination with chemotherapy in xenograft models of human lymphoma
Frank Herting, Thomas Friess, Sabine Bader, Gunter Muth, Gabriele Hölzlwimmer, Natascha Rieder, Pablo Umana & Christian Klein
Pages: 2151-5160
Published online: 04 Feb 2014
AbstractforEnhanced anti-tumor activity of the glycoengineered type II CD20 antibody obinutuzumab (GA101) in combination with chemotherapy in xenograft models of human lymphoma | Full Text | References | PDF (2.9 MB) | Supplemental
  • 2214 Views
  • 42 CrossRef citations
  • 0Altmetric
Open Access
Article
Detection of T-cell receptor γ gene rearrangement in paraffin-embedded T or natural killer/T-cell lymphoma samples using the BIOMED-2 protocol
Tomoko Miyata-Takata, Katsuyoshi Takata, Sachiko Yamanouchi, Yasuharu Sato, Mai Harada, Takashi Oka, Takehiro Tanaka, Yoshinobu Maeda, Mitsune Tanimoto & Tadashi Yoshino
Pages: 2161-2164
Published online: 24 Jan 2014
AbstractforDetection of T-cell receptor γ gene rearrangement in paraffin-embedded T or natural killer/T-cell lymphoma samples using the BIOMED-2 protocol | Full Text | References | PDF (890.2 KB) | Supplemental
  • 238 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Bendamustine and melphalan kill myeloma cells similarly through reactive oxygen species production and activation of the p53 pathway and do not overcome resistance to each other
Sylvanie Surget, Emilie Lemieux-Blanchard, Sophie Maïga, Géraldine Descamps, Steven Le Gouill, Philippe Moreau, Martine Amiot & Catherine Pellat-Deceunynck
Pages: 2165-2173
Published online: 17 Feb 2014
AbstractforBendamustine and melphalan kill myeloma cells similarly through reactive oxygen species production and activation of the p53 pathway and do not overcome resistance to each other | Full Text | References | PDF (944.3 KB) | Supplemental
  • 546 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
Polymorphism in IKZF1 gene affects age at onset of childhood acute lymphoblastic leukemia
Patryk Górniak, Agata Pastorczak, Beata Zalewska-Szewczyk, Monika Lejman, Joanna Trelińska, Marta Chmielewska, Agnieszka Sokół-Jeżewska, Jerzy Kowalczyk, Tomasz Szczepanski, Michał Matysiak, Bernarda Kazanowska, Wojciech Mlynarski & for the Polish Pediatric Leukemia/Lymphoma Study Group
Pages: 2174-2178
Published online: 02 Apr 2014
AbstractforPolymorphism in IKZF1 gene affects age at onset of childhood acute lymphoblastic leukemia | Full Text | References | PDF (338.9 KB) | Supplemental
  • 299 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK/JNK
Yan Liu, Jiao Ge, Qiang Li, Xia Guo, Ling Gu, Zhi-Gui Ma, Xi-Hong Li & Yi-Ping Zhu
Pages: 2179-2188
Published online: 03 Apr 2014
AbstractforLow-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK/JNK | Full Text | References | PDF (3.2 MB) | Supplemental
  • 395 Views
  • 24 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
MST1/2 and YAP1 gene expression in acute myeloid leukemia
Shamsi Safari, Abolfazl Movafagh, Davood Zare-Adollahi, Mojtaba Ghadiani, Sahand Riazi-Isfahani, Nioufar Safavi-Naini & Mir Davood Omrani
Pages: 2189-2191
Published online: 17 Feb 2014
First Page PreviewforMST1/2 and YAP1 gene expression in acute myeloid leukemia | Full Text | References | PDF (107.1 KB) | Supplemental
  • 512 Views
  • 7 CrossRef citations
  • 0Altmetric

Letter

Letter
Concurrent chronic lymphocytic leukemia and cutaneous T cell lymphoma: a case series
Lotika Singh, Jessica L. Boulavsky & Madeleine Duvic
Pages: 2192-2195
Published online: 06 Feb 2014
First Page PreviewforConcurrent chronic lymphocytic leukemia and cutaneous T cell lymphoma: a case series | Full Text | References | PDF (176.5 KB) | Supplemental
  • 165 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Dexamethasone, methotrexate, ifosfamide, l-asparaginase and etoposide (SMILE) chemotherapy for relapsed or refractory adult lymphoblastic lymphoma
Won Jin Chang, Young Hyeh Ko, Seok Jin Kim & Won Seog Kim
Pages: 2196-2198
Published online: 17 Feb 2014
First Page PreviewforDexamethasone, methotrexate, ifosfamide, l-asparaginase and etoposide (SMILE) chemotherapy for relapsed or refractory adult lymphoblastic lymphoma | Full Text | References | PDF (96.4 KB) | Supplemental
  • 498 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation?
Antonella Zagaria, Luisa Anelli, Paola Casieri, Nicoletta Coccaro, Giuseppina Tota, Crescenzio Francesco Minervini, Angela Minervini, Luciana Impera, Claudia Brunetti, Paola Orsini, Angelo Cellamare, Giorgina Specchia & Francesco Albano
Pages: 2199-2201
Published online: 24 Feb 2014
First Page PreviewforBCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation? | Full Text | References | PDF (786.8 KB) | Supplemental
  • 295 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
KIT D816V mutation detection: a comparative study using peripheral blood, bone marrow aspirate and bone marrow trephine samples for detection of KIT mutations in patients with systemic mastocytosis
Rishu Agarwal, Michelle McBean, Chelsee Hewitt & David A. Westerman
Pages: 2202-2203
Published online: 28 Jan 2014
CitationforKIT D816V mutation detection: a comparative study using peripheral blood, bone marrow aspirate and bone marrow trephine samples for detection of KIT mutations in patients with systemic mastocytosis | Full Text | References | PDF (90.2 KB) | Supplemental
  • 230 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Expression and subcellular localization of cyclin-dependent kinase inhibitor p27 does not correlate with proliferation pattern of mantle lymphoma cells
Sophie Bustany, Julie Cahu, Alexandra Moros, Xavier Troussard, Roué Gaël & Brigitte Sola
Pages: 2204-2206
Published online: 06 Feb 2014
First Page PreviewforExpression and subcellular localization of cyclin-dependent kinase inhibitor p27 does not correlate with proliferation pattern of mantle lymphoma cells | Full Text | References | PDF (324.2 KB) | Supplemental
  • 98 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis
Monica Maccaferri, Giovanna Leonardi, Roberto Marasca, Elisabetta Colaci, Ambra Paolini, Francesco Soci, Fabio Forghieri, Leonardo Potenza, Franco Narni & Mario Luppi
Pages: 2207-2208
Published online: 28 Jan 2014
CitationforRuxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis | Full Text | References | PDF (247.3 KB) | Supplemental
  • 390 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Rare occurrence of SET binding protein 1 mutation in patients with acute lymphoblastic leukemia, mixed phenotype acute leukemia and chronic myeloid leukemia in blast crisis
Meiyu Chen, Hong Yao, Suning Chen, Qinrong Wang, Qian Wang, Lijun Wen, Jundan Xie, Lili Qin, Lili Wu, Huiying Qiu & Jiannong Cen
Pages: 2209-2210
Published online: 28 Jan 2014
CitationforRare occurrence of SET binding protein 1 mutation in patients with acute lymphoblastic leukemia, mixed phenotype acute leukemia and chronic myeloid leukemia in blast crisis | Full Text | References | PDF (89.2 KB) | Supplemental
  • 142 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Evaluation of comorbidity indexes in the outcome of elderly patients treated for acute lymphoblastic leukemia
Colombe Saillard, Anne Etienne, Aude Charbonnier, Evelyne D’incan, Jérôme Rey, Christine Arnoulet, Marie Joelle Mozziconacci, Didier Blaise, Norbert Vey & Thomas Prebet
Pages: 2211-2212
Published online: 28 Jan 2014
CitationforEvaluation of comorbidity indexes in the outcome of elderly patients treated for acute lymphoblastic leukemia | Full Text | References | PDF (90.4 KB) | Supplemental
  • 246 Views
  • 6 CrossRef citations
  • 0Altmetric
Letter
Drug–drug interaction between bosutinib and warfarin
Ashish V. Chintakuntlawar, Heidi D. Finnes, Ayalew Tefferi & Animesh Pardanani
Pages: 2213-2214
Published online: 28 Jan 2014
CitationforDrug–drug interaction between bosutinib and warfarin | Full Text | References | PDF (87 KB) | Supplemental
  • 298 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Paroxysmal nocturnal hemoglobinuria is not a cause of anemia in patients with myelofibrosis
Aziz Nazha, Jeffrey L. Jorgensen & Srdan Verstovsek
Pages: 2215-2216
Published online: 24 Jan 2014
CitationforParoxysmal nocturnal hemoglobinuria is not a cause of anemia in patients with myelofibrosis | Full Text | References | PDF (84 KB) | Supplemental
  • 142 Views
  • 5 CrossRef citations
  • 0Altmetric

Short Communication

Article
The protective role of MTR A2756G polymorphisms in childhood acute lymphoblastic leukemia remains inconclusive
Su-yi Li, Jie-yu Ye, En-yu Liang & Mo Yang
Pages: 2217-2218
Published online: 28 Jan 2014
CitationforThe protective role of MTR A2756G polymorphisms in childhood acute lymphoblastic leukemia remains inconclusive | Full Text | References | PDF (200.1 KB) | Supplemental
  • 73 Views
  • 3 CrossRef citations
  • 0Altmetric

Explore articles